Janus Henderson Investors US’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $121M | Sell |
1,454,778
-29,463
| -2% | -$2.44M | 0.1% | 255 |
|
|
2016
Q4 | $118M | Sell |
1,484,241
-76,935
| -5% | -$6.1M | 0.1% | 259 |
|
|
2016
Q3 | $109M | Buy |
1,561,176
+70,947
| +5% | +$4.97M | 0.09% | 278 |
|
|
2016
Q2 | $57.8M | Buy |
1,490,229
+42,690
| +3% | +$1.66M | 0.05% | 395 |
|
|
2016
Q1 | $58.6M | Buy |
1,447,539
+218,898
| +18% | +$8.87M | 0.05% | 398 |
|
|
2015
Q4 | $109M | Buy |
1,228,641
+455,419
| +59% | +$40.4M | 0.09% | 271 |
|
|
2015
Q3 | $57.2M | Sell |
773,222
-12,258
| -2% | -$907K | 0.05% | 383 |
|
|
2015
Q2 | $63.5M | Sell |
785,480
-1,422
| -0.2% | -$115K | 0.05% | 400 |
|
|
2015
Q1 | $33M | Buy |
+786,902
| New | +$33M | 0.03% | 533 |
|